Molecular diagnosis of thyroid cancer——94th Annual Meeting & Expo (2012.6.22-27) of Endocrine Society USA

VernacularTitle:甲状腺癌的分子诊断——94届美国内分泌年会(2012.6.22-27)
Author: Shuhang XU ; Chao LIU
Publication Type:Journal Article
Keywords: Thyroid carcinoma; Well-differentiated carcinomas; Molecular makers; Molecular diagnosis
From: Chinese Journal of Endocrinology and Metabolism 2012;28(8):691-694
CountryChina
Language:Chinese
Abstract: Fine-needle aspiration biopsy is the mainstay of preoperative diagnosis of thyroid cancer which is the most common type of endocrine malignancy.However,some aspirates yield indeterminate cytology and there is no clear recommendation for the management on these situations.The use of emerging molecular markers such as BRAF、RET、PAX8/PPARγ will likely improve the diagnosis of malignancy in thyroid nodules and facilitate more individualized therapeutic options and postoperative management.Some markers have been extensively characterized and introduced into clinical practice.